Daniel E. Greenleaf
2017
In 2017, Daniel E. Greenleaf earned a total compensation of $2.4M as President & Chief Executive Officer at BioScrip, a 46% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $268,250 |
|---|---|
| Salary | $725,000 |
| Stock Awards | $1,376,343 |
| Other | $24,956 |
| Total | $2,394,549 |
Greenleaf received $1.4M in stock awards, accounting for 57% of the total pay in 2017.
Greenleaf also received $268.3K in non-equity incentive plan, $725K in salary and $25K in other compensation.
Rankings
In 2017, Daniel E. Greenleaf's compensation ranked 4,649th out of 14,666 executives tracked by ExecPay. In other words, Greenleaf earned more than 68.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,649 out of 14,666 | 68th |
Division Services | 893 out of 2,424 | 63rd |
Major group Health Services | 78 out of 224 | 65th |
Industry group Home Health Care Services | 10 out of 31 | 68th |
Industry Home Health Care Services | 10 out of 31 | 68th |
Source: SEC filing on April 4, 2018.
Greenleaf's colleagues
We found five more compensation records of executives who worked with Daniel E. Greenleaf at BioScrip in 2017.